Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | MMP1 | P03956 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.43 |
| ▸ | MMP3 | P08254 | 1/20 | 0.43 |
| ▸ | MMP9 | P14780 | 1/20 | 0.43 |
| ▸ | MMP8 | P22894 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | GFER | P55789 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL217411 | 1.00 | — | — | |
| SCHEMBL4396572 | 1.00 | CYP2D6 (0.63) | CYP2D6TDP1EPHX1ALDH1A1CYP3A4 | |
| Hydrochloric Acid SCHEMBL4316280 | 0.97 | — | — | |
| SCHEMBL5519295 | 0.91 | CYP2D6 (0.55) | CYP2D6TDP1EPHX1ALDH1A1CYP3A4 | |
| SCHEMBL481633 | 0.91 | CYP2D6 (0.55) | CYP2D6TDP1EPHX1ALDH1A1CYP3A4 | |
| SCHEMBL3648058 | 0.91 | CYP2D6 (0.55) | CYP2D6TDP1EPHX1ALDH1A1CYP3A4 | |
| SCHEMBL1118505 | 0.91 | CYP2D6 (0.55) | CYP2D6TDP1EPHX1ALDH1A1CYP3A4 | |
| SCHEMBL14718558 | 0.91 | CYP2D6 (0.55) | CYP2D6TDP1EPHX1ALDH1A1CYP3A4 | |
| SCHEMBL8396255 | 0.90 | — | — | |
| SCHEMBL3133945 | 0.90 | CYP2D6 (0.77) | CYP2D6TDP1EPHX1CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12594147-B2 | Curable composition for use in a high temperature lithography-based photopolymerization process and method of producing crosslinked polymers therefrom | ALIGN TECHNOLOGY, INC. (US) | 2026-04-07 | — | — | US | disclosed |
| US-20250197658-A1 | ANTIOXIDANT STABILIZERS FOR DIRECT FABRICATION OF ORTHODONTIC APPLIANCES | ALIGN TECHNOLOGY, INC. | 2025-06-19 | — | — | US | disclosed |
| EP-4272962-A2 | CURABLE COMPOSITION FOR USE IN A HIGH TEMPERATURE PHOTOPOLYMERISATION METHOD ON A LITHOGRAPHY BASIS AND PROCESS FOR THE PREPARATION OF CROSS-LINKED POLYMERS THEREFROM | Align Technology, Inc. (US) | 2023-11-08 | — | — | EP | disclosed |
| EP-3564282-B1 | CURABLE COMPOSITION FOR USE IN A HIGH TEMPERATURE PHOTOPOLYMERISATION METHOD ON A LITHOGRAPHY BASIS AND PROCESS FOR THE PREPARATION OF CROSS-LINKED POLYMERS THEREFROM | ALIGN TECHNOLOGY INC (US) | 2023-06-07 | — | — | EP | disclosed |
| US-11542362-B2 | Curable composition for use in a high temperature lithography-based photopolymerization process and method of producing crosslinked polymers therefrom | ALIGN TECHNOLOGY, INC. (US) | 2023-01-03 | — | — | US | disclosed |
| US-10954334-B2 | — | — | 2021-03-23 | — | — | US | disclosed |
| US-20200040130-A1 | CURABLE COMPOSITION FOR USE IN A HIGH TEMPERATURE LITHOGRAPHY-BASED PHOTOPOLYMERIZATION PROCESS AND METHOD OF PRODUCING CROSSLINKED POLYMERS THEREFROM | ALIGN TECHNOLOGY, INC. | 2020-02-06 | — | — | US | disclosed |
| EP-3564282-A1 | CURABLE COMPOSITION FOR USE IN A HIGH TEMPERATURE PHOTOPOLYMERISATION METHOD ON A LITHOGRAPHY BASIS AND PROCESS FOR THE PREPARATION OF CROSS-LINKED POLYMERS THEREFROM | Align Technology, Inc. (US) | 2019-11-06 | — | — | EP | disclosed |
| US-20090306133-A1 | New Acetyl Coenzyme A Carboxylase (ACC) Inhibitors And Uses In Treatments Of Obesity And Diabetes Mellitus - 087 | ASTRAZENECA AB (SE) | 2009-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090306133-A1 | New Acetyl Coenzyme A Carboxylase (ACC) Inhibitors And Uses In Treatments Of Obesity And Diabetes Mellitus - 087 | ACACA, ACACB, ACAT1 | CYP2D6 1817/4885TDP1 4840/4885EPHX1 959/4885 |
| US-12594147-B2 | Curable composition for use in a high temperature lithography-based photopolymerization process and method of producing crosslinked polymers therefrom | MACF1, DYNC1LI2, DYNLL2 | CYP2D6 3814/4885TDP1 1835/4885EPHX1 4155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.